Jonathan D. Parsons

Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model

Recent advances in targeted antibacterial therapy basing on nanomaterials

In Vitro Characterization of the Antibacterial Spectrum of Novel Bacterial Type II Topoisomerase Inhibitors of the Aminobenzimidazole Class

Crystal Structures of Escherichia coli Topoisomerase IV ParE Subunit (24 and 43 Kilodaltons): a Single Residue Dictates Differences in Novobiocin Potency against Topoisomerase IV and DNA Gyrase